10-Q: Agrify Pivots to Hemp-THC Amidst Deep Losses

Agrify Corporation shifts focus to hemp-derived THC products after divesting legacy businesses, reporting significant net losses and increased operating expenses in its latest quarterly filing.

Summary

• Agrify is repositioning as a developer and distributor of hemp-derived THC products, including beverages (Seorita) and edibles (incredibles, Beboe).
• The company divested its Cultivation Business on December 31, 2024, and discontinued its Extraction Business on March 30, 2025.
• Revenue from continuing operations for the three months ended June 30, 2025, was $2.042 million, up from $0 in the prior year, primarily due to new hemp-derived product sales and royalty revenue.
• Gross profit for the quarter was $0.682 million, representing a 33.4% gross margin.
• Selling, General, and Administrative (SG&A) expenses surged by 1005% to $7.480 million for the quarter, driven by sales and marketing for the new product lines.
• Operating loss from continuing operations widened to $6.798 million for the quarter, compared to $0.853 million in the prior year.
• Net loss attributable to Agrify Corporation for the quarter was $7.360 million, an increase from $2.972 million in the same period last year.
• Cash and cash equivalents increased to $40.956 million as of June 30, 2025, from $31.170 million at December 31, 2024, primarily due to financing activities.
• Net cash used in operating activities for the six months ended June 30, 2025, was $15.138 million, significantly higher than $4.816 million in the prior year.
• The company secured $30.0 million in new secured convertible notes in May 2025, bringing total borrowings under these notes to $40.0 million.
• Material weaknesses in internal control over financial reporting persist as of June 30, 2025.

Sentiment

Score: 3

Explanation: The company is undergoing a significant strategic pivot, which is a positive long-term move, but current financial results show substantial losses, high cash burn from operations, and increased expenses. The reliance on related-party financing and persistent internal control weaknesses, coupled with ongoing material litigation, indicate high operational and financial risk. While the new revenue stream is a start, profitability remains a distant goal.

Positives

• Successful strategic pivot to the hemp-derived THC market, acquiring new brands like Seorita and MC Brands (incredibles).
• Generated $2.042 million in revenue from continuing operations for the quarter, a significant increase from zero in the prior year, demonstrating initial traction in the new business segment.
• Improved cash position to $40.956 million, providing liquidity for ongoing operations and strategic initiatives.
• Regained compliance with Nasdaq listing requirements (stockholders' equity and minimum bid price).

Negatives

• Significant net loss of $7.360 million for the quarter and $8.986 million for the six months, indicating substantial unprofitability.
• Operating loss from continuing operations widened considerably to $6.798 million for the quarter and $10.499 million for the six months.
• Selling, General, and Administrative (SG&A) expenses increased by 1005% for the quarter and 406% for the six months, indicating high costs associated with the business transition and growth efforts.
• Net cash used in operating activities increased significantly to $15.138 million for the six months, highlighting a substantial cash burn from operations.
• Reliance on related-party financing for liquidity, with $37.0 million in related party debt as of June 30, 2025.
• Ongoing material weaknesses in internal control over financial reporting, indicating potential risks in financial reporting accuracy and compliance.
• Multiple active legal proceedings with significant potential liabilities, including claims of $14.4 million, $7.0 million, and $3.0 million.

Risks

• Inability to generate sufficient taxable income to utilize net operating loss (NOL) carryforwards due to Section 382 limitations from historical ownership changes.
• Uncertainty regarding the outcome of multiple ongoing legal proceedings (Bud & Marys, Bowdoin Construction Corp., McCutchan, Inc., former sales VP suit), which could result in significant financial liabilities.
• Potential for adverse results from litigation could harm business and financial performance.
• Inability to fully remediate material weaknesses in internal control over financial reporting, which could affect financial reporting reliability.
• Dependence on third-party co-manufacturers and distributors, with risks of supply disruption or inability to meet demand.
• Exposure to concentration of credit risk with significant related-party and third-party customers.
• Risk of not being able to raise additional capital on acceptable terms if required, adversely affecting business and financial condition.
• The Call Option and Put Option provisions related to the MC Brands acquisition introduce complexity and potential future transactions.
• Transfer restrictions on acquired assets/membership interests for 5 years, requiring Seller's consent and subject to Right of First Offer (ROFO) and Right of First Refusal (ROFR).

Future Outlook

The company is strategically shifting its focus to hemp-derived THC products and related licensing, aiming for continued expansion in this segment. It anticipates future availability of its Seorita brand in premier on-premises destinations. The company is evaluating the impact of recently enacted tax legislation (OBBA) on its future financial position, results of operations, and cash flows.

Management Comments

• We are committed to ensuring that the carrying amounts of our assets are appropriately assessed and adjusted for any impairment, reflecting a true and fair view of our financial position.
• We continue to actively seek alternative and/or additional co-manufacturing facilities with adequate capacity and capability for the production of our various products to minimize transportation costs as well as mitigate the risk of disruption in production.
• Our ability to estimate demand for our products is imprecise, particularly with new products, and may be less precise during periods of rapid growth, including in new markets.
• If we materially underestimate demand for our products and/or are unable to secure sufficient ingredients or raw materials and/or procure adequate co-manufacturing arrangements and/or obtain adequate or timely shipment of our products, we might not be able to satisfy demand on a short-term basis.
• We believe this is a meritless claim and have responded to various discovery requests.
• Management, with the oversight of the Audit Committee of our Board of Directors, continue to focus on remediating the material weaknesses identified in the design and operation of our internal control over financial reporting, including adding additional qualified personnel, further documentation and implementation of control procedures and the implementation of control monitoring.

Industry Context

Agrify is undergoing a significant strategic transformation, exiting the capital-intensive cultivation and extraction solutions segments of the cannabis industry to focus on the rapidly evolving hemp-derived THC consumer products market. This pivot aligns with a broader trend of companies seeking opportunities in the less federally restricted hemp space, particularly for consumable products like beverages and edibles. The acquisition of established brands like Seorita and incredibles positions Agrify to leverage existing market recognition, but it also places the company in a highly competitive and still-developing regulatory landscape for hemp-derived products.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Bud & Marys Litigation: Company provided default notice on September 15, 2022. Bud & Marys filed a complaint on October 5, 2022, alleging unfair/deceptive trade practices, breach of contract, and conversion. Company counterclaimed for breach of contract, unjust enrichment, and enforcement of guarantees. Company reserved $14.4 million as of December 31, 2024, and funded $1.5 million into escrow in January 2025 for this and other claims.
• Bowdoin Construction Corp. Litigation: Filed on February 22, 2023, alleging breach of contract by the Company and Bud & Marys for nonpayment of approximately $7.0 million. Two subcontractors (Hannon Electric, Inc. and Electric Supply Center Corp) filed separate consolidated suits for $1.498 million and $93 thousand, respectively. Company denied liability. Subject to the $1.5 million escrow.
• McCutchan, Inc. Litigation: Filed on March 5, 2024, alleging breach of contract, voidable contract, interference, unjust enrichment, and defamation, seeking no less than $3 million. Subject to the $1.5 million escrow.
• Former Sales Vice President Suit: Filed on February 9, 2022, claiming back wages, commission, and equity under Massachusetts labor laws. Company believes the claim is meritless.

Related Party Transactions

• Sale of Cultivation Business to CP Acquisitions, LLC (affiliated with former CEO Raymond Chang) on December 31, 2024, with consideration being the assumption of approximately $7 million in secured indebtedness held by CP.
• Acquisition of MC Brands LLC (incredibles brand) from VCP IP Holdings, LLC (indirectly wholly-owned subsidiary of Green Thumb Industries Inc.) for $5.1 million cash on May 20, 2025.
• Licensing of RYTHM and Beboe brands from Green Thumb for hemp-derived THC products.
• Licensing of incredibles brand back to GTI Core (Green Thumb subsidiary) for their state-licensed cannabis business, with monthly sales-based royalty fees.
• Issued secured convertible notes (November 2024 Note and May 2025 Notes) totaling $40.0 million to RSLGH, LLC (Green Thumb subsidiary) and other third-party accredited investors. Interest payments on these notes are primarily in pre-funded warrants.
• Amended and Restated Shared Services Agreement with Vision Management Services, LLC (Green Thumb subsidiary) on May 20, 2025, for administrative, supply chain, operations, sales, marketing, and technical services. Fees are 125% of costs for non-dedicated personnel (up to $3.0 million annually) and 100% for dedicated personnel/third-party costs, payable in cash or pre-funded warrants/Common Stock.
• Accrued consulting fees with Green Thumb of approximately $1.3 million as of June 30, 2025.
• Net related party payable to Green Thumb Industries of $38.787 million as of June 30, 2025, including $37.0 million in convertible notes payable.

Stakeholder Impact

• Shareholders: Significant net losses and increased cash burn could lead to further share price volatility and potential dilution from future capital raises (especially if warrants are converted). The strategic pivot introduces new market opportunities but also new risks.
• Employees: Workforce reduction of nine employees on April 1, 2025, due to the discontinuation of the Extraction Business. Ongoing remediation of internal control weaknesses may impact employee workload and responsibilities.
• Customers: The shift to hemp-derived THC products aims to serve a growing market, potentially benefiting customers seeking low-sugar, low-calorie alternatives to alcoholic beverages. Discontinuation of cultivation and extraction businesses means former customers in those segments will need to find new providers.
• Suppliers: Changes in business focus will lead to new supplier relationships for hemp-derived products and a cessation of relationships for legacy businesses.
• Creditors: New secured convertible notes provide liquidity but also increase debt burden. Related-party debt constitutes a significant portion of liabilities.

Next Steps

• Continue expansion and future availability of Seorita brand in premier on-premises destinations.
• Issue additional 11,373 pre-funded warrants on September 1, 2025, in lieu of cash interest on the November 2024 Note.
• Begin interest payments on May 2025 Notes in pre-funded warrants starting September 1, 2025.
• Remediate material weaknesses in internal control over financial reporting by adding qualified personnel, further documentation, and implementing control monitoring.
• Assess the potential impact of the One Big Beautiful Bill (OBBA) tax legislation on future financials.
• Seller to obtain full and unconditional release of Seller Affiliate Liens within 90 days of the MC Brands acquisition closing.

Key Dates

Recommendation

Agrify's strategic pivot to hemp-derived THC products is a high-risk, high-reward move. While the company has secured significant related-party financing and is generating initial revenue in its new segment, the magnitude of its net losses, substantial cash burn from operations, and soaring SG&A expenses indicate severe unprofitability. The persistence of material weaknesses in internal controls and the burden of multiple ongoing legal proceedings with significant potential liabilities further compound the risk. The company's financial health is heavily reliant on continued financing, and the path to sustainable profitability is unclear. For a seasoned investor, the current financial state and operational challenges outweigh the speculative upside of the new business direction, warranting a 'sell' recommendation to mitigate further downside risk.

Keywords

Hemp-derived THC, Cannabis Industry, Consumer Packaged Goods, Seorita, incredibles, Beboe, SEC Filing, Quarterly Report, Financial Performance, Strategic Pivot, Liquidity, Litigation Risk, Internal Controls, Related Party Transactions, AGFY